Search
Why do some patients respond to immunotherapy while others do not? Blood may hold the answer.
A team of researchers from MSK and Weill Cornell Medicine is expanding the understanding of how a decades-old treatment for bladder cancer works — an understanding that could help improve the effectiveness of immunotherapies more broadly.
Electronic nose (e-nose) technology identified early-stage lung cancer with high reliability in a prospective observational clinical trial conducted at Memorial Sloan Kettering Cancer Center (MSK).
What's it like being LGBTQ in the world of science? We asked some MSK scientists to find out.
Mitochondria provide both the energy cells need to survive and the building blocks they need to grow and divide. Researchers at the Sloan Kettering Institute reveal for the first time how mitochondria choose between these opposing paths — and what implications it may have for cancer.
A high-dose radiation treatment is effective for pancreatic cancer patients who cannot have surgery.
Science could lead to a new type of opioid drug that blocks pain but has a lower potential for addiction or abuse.
Follow these guidelines for holding difficult yet important end-of-life conversations.